1. Charafeddine MA, Olson SH, Mukherji D, Temraz SN, Abou-Alfa GK, Shamseddine AI. Proportion of cancer in a Middle Eastern country attributable to established risk factors. BMC Cancer. 2017;17:337.
2. Hamadeh RR, Borgan SM, Sibai AM. Cancer Research in the Arab World: a review of publications from seven countries between 2000-2013. Sultan Qaboos Univ Med J. 2017;17:e147-54.
3. Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015. JAMA Oncol. 2017;3:1683-91.
4. Ananthakrishnan A, Gogineni V, Saeian K. Epidemiology of primary and secondary liver cancers. Semin Intervent Radiol. 2006;23:47-63.
5. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:e359-86.
6. Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995;31:1237-48.
7. Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys. 2007;68:13-23.
8. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol. 1954;30:969-85.
9. Lau WY, Teoh YL, Win KM, Lee RC, de Villa VH, Kim YH, et al. Current role of selective internal radiation with yttrium-90 in liver tumors. Future Oncol. 2016;12:1193-204.
10. Pluda JM. Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies. Semin Oncol. 1997;24:203-18.
11. Sangro B, Iñarrairaegui M, Bilbao JI. Radioembolization for hepatocellular carcinoma. J Hepatol. 2012;56:464-73.
12. Khor AY, Toh Y, Allen JC, Ng DC, Kao YH, Zhu G, et al. Survival and pattern of tumor progression with yttrium-90 microsphere radioembolization in predominantly hepatitis B Asian patients with hepatocellular carcinoma. Hepatol Int. 2014;8:395-404.
13. Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, et al. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. Lancet Oncol. 2017;18:1624-36.
14. Gibbs P, Do C, Lipton L, Cade DN, Tapner MJ, Price D, et al. Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma. BMC Cancer. 2015;15:802.
15. Kennedy A, Brown DB, Feilchenfeldt J, Marshall J, Wasan H, Fakih M, et al. Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus. J Gastrointest Oncol. 2017;8:1079-99.
16. Cremonesi M, Chiesa C, Strigari L, Ferrari M, Botta F, Guerriero F, et al. Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective. Front Oncol. 2014;4:210.
17. Matz LR, Lawrence-Brown MM. Ischaemic cholecystitis and infarction of the gallbladder. Aust N Z J Surg. 1982;52:466-71.
18. Paprottka KJ, Schoeppe F, Ingrisch M, Rubenthaler J, Sommer NN, De Toni E, et al. Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients. Eur J Nucl Med Mol Imaging. 2017;44:1185-93.
19. Schobert I, Chapiro J, Nezami N, Hamm CA, Gebauer B, Lin M, et al. Quantitative imaging biomarkers for yttrium-90 distribution on bremsstrahlung single photon emission computed tomography after resin-based radioembolization. J Nucl Med. 2019; doi:10.2967/jnumed.118.219691.
20. Dezarn WA, Cessna JT, DeWerd LA, Feng W, Gates VL, Halama J, et al. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys. 2011;38:4824-45.
21. Abdelmaksoud MH, Louie JD, Kothary N, Hwang GL, Kuo WT, Hofmann LV, et al. Consolidation of hepatic arterial inflow by embolization of variant hepatic arteries in preparation for yttrium-90 radioembolization. J Vasc Interv Radiol. 2011;22:1364-71.e1.
22. Bilbao JI, Garrastachu P, Herráiz MJ, Rodriguez M, Inarrairaegui M, Rodriguez J, et al. Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors. Cardiovasc Intervent Radiol. 2010;33:523-31.
23. Chuang VP, Wallace S. Hepatic arterial redistribution for intraarterial infusion of hepatic neoplasms. Radiology. 1980;135:295-9.
24. Koehler RE, Korobkin M, Lewis F. Arteriographic demonstration of collateral arterial supply to the liver after hepatic artery ligation. Radiology. 1975;117:49-54.
25. Borggreve AS, Landman A, Vissers CMJ, De Jong CD, Lam M, Monninkhof EM, et al. Radioembolization: Is prophylactic embolization of hepaticoenteric arteries necessary? A systematic review. Cardiovasc Intervent Radiol. 2016;39:696-704.
26. Sangro B, Carpanese L, Cianni R, Golfieri R, Gasparini D, Ezziddin S, et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. Hepatology. 2011;54:868-78.
27. Lam M, Banerjee S, Louie JD, Abdelmaksoud MHK, Iagaru AH, Ennen RE, et al. Root cause analysis of gastroduodenal ulceration after yttrium-90 radioembolization. Cardiovasc Intervent Radiol. 2013;36:1536-47.
28. Ward TJ, Louie JD, Sze DY. Yttrium-90 radioembolization with resin microspheres without routine embolization of the gastroduodenal artery. J Vasc Interv Radiol. 2017;28:246-53.
29. Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek Jr AA, Kulik L, et al. Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol. 2007;30:571-92.
30. Polyzonis MB, Tsikaras P, Hytiroglou P, Agios A. Further observations on the vascular system of the gallbladder in man. Bull Assoc Anat (Nancy). 1989;73:25-8.
31. Powerski M, Busse A, Seidensticker M, Fischbach F, Seidensticker R, Strach K, et al. Prophylactic embolization of the cystic artery prior to radioembolization of liver malignancies--an evaluation of necessity. Cardiovasc Intervent Radiol. 2015;38:678-84.
32. Theysohn JM, Müller S, Schlaak JF, Ertle J, Schlosser TW, Bockisch A, et al. Selective internal radiotherapy (SIRT) of hepatic tumors: how to deal with the cystic artery. Cardiovasc Intervent Radiol. 2013;36:1015-22.
33. Kim DY, Park BJ, Kim YH, Han KH, Cho SB, Cho KR, et al. Radioembolization with yttrium-90 resin microspheres in hepatocellular carcinoma: a multicenter prospective study. Am J Clin Oncol. 2015;38:495-501.
34. Li MD, Chu KF, DePietro A, Wu V, Wehrenberg-Klee E, Zurkiya O, et al. Same-day yttrium-90 radioembolization: feasibility with resin microspheres. J Vasc Interv Radiol. 2019;30:314-9.